Clinical Trial Update: The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining the effects of intramuscular testosterone undecanoate on biochemical and anthropometric measures in men with metabolic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Metabolic Syndrome

Drugs mentioned

• testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Metabolic Syndrome, Hypogonadism | Phase 3 | Status: UNKNOWN